KCNJ2 and Anxiety: The expression of Kir2.1 in NAcSh ensembles significantly inhibited ensemble activation (Fig. 7i, j) and reduced the active nose pokes after 30-day withdrawal (Fig. 7k, l), but did not change locomotor activity and anxiety level (Supplementary Fig. S9a–c).